Friedreich's ataxia is an inherited, degenerative neuromuscular disorder that initially impairs motor function, such as gait and coordination, but can lead to scoliosis, heart disease, vision loss and diabetes. Cognitive function is not affected. The disease is progressively debilitating, and ultimately requires full-time use of a wheelchair. One in 50,000 Americans has FA.
FA is caused by reduced expression of a mitochondrial protein called frataxin (FXN) due to a two mutated or abnormal copies of the FXN gene.
Researchers report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mouse model of Friedreich's ataxia (FA) measurably halted cellular damage caused by the degenerative disease.
The findings, published in Science Translational Medicine, suggest a potential therapeutic approach for a disease that currently is considered incurable.
In their study, researchers used a transgenic mouse model that expresses two mutant human FXN transgenes, and exhibits the resulting progressive neurological degeneration and muscle weakness.
Human hematopoietic stem and progenitor cells (HSPCs), derived from bone marrow, have become a primary vehicle for efforts to replace or regenerate cells destroyed by a variety of diseases. Previous research by the researchers had shown that transplanting wildtype or normal mouse HSPCs resulted in long-term kidney, eye and thyroid preservation in a mouse model of cystinosis, another genetic disorder.
In this study, the team transplanted wildtype HSPCs into an FA mouse model, reporting that the HSPCs engrafted and soon differentiated into macrophages in key regions of the mice's brain and spinal cord where they appeared to transfer wildtype FXN into deficient neurons and muscle cells.
HSPC transplanted IN FA mouse model showed abrogation of muscle weakness and locomotor deficits as was degeneration of large sensory neurons in the dorsal root ganglia (DRGs) and mitochondrial capacity was improved in brain, skeletal muscle, and heart. Transplanted HSPCs engrafted and then differentiated into microglia in the brain and spinal cord and into macrophages in the DRGs, heart, and muscle of YG8R FRDA mice.
Authors observed the transfer of wild-type frataxin and Cox8 mitochondrial proteins from HSPC-derived microglia/macrophages to FRDA mouse neurons and muscle myocytes in vivo.
"Transplantation of wildtype mouse HSPCs essentially rescued FA-impacted cells," said the senior author, "Frataxin expression was restored. Mitochondrial function in the brains of the transgenic mice normalized, as did in the heart. There was also decreased skeletal muscle atrophy."
The scientists note that the mouse model is not perfect mirror of human FA. Disease progression is somewhat different and the precise pathology in mice is not fully known. However, the findings are encouraging and point toward a potential treatment for a disease that currently has none
.
http://ucsdnews.ucsd.edu/pressrelease/transplanted_hematopoietic_stem_cells_reverse_damage_caused_by_neuromuscula
http://stm.sciencemag.org/content/9/413/eaaj2347
Transplanted hematopoietic stem cells reverse damage caused by neuro-muscular disorder
- 1,521 views
- Added
Edited
Latest News
Pixelated chemical displays offer versatile liquid handling
Cells mechanical forces linked to immune system
Characterization of a new Leishmania major strain for use in a controlled human infection model
Stress granules do not suppress mRNA translation!
How the brain paralyzes you while you sleep
Other Top Stories
Slow heart rate does not increase risk of heart disease
Common Brain Mechanisms of Chronic Pain and Addiction
Why I tense up when you watch me
Marijuana use does not cause cognitive decline
Why are habits so hard to break?
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
Vesicular Glutamate Transporters (SLCA17 A6, 7, 8) Control Synaptic Phosphate Levels
Incorporating Tumor-Associated Macrophages into Engineered Models of Glioma
Prolactinomas
Mechanical Stiffness Controls Dendritic Cell Metabolism and Function
Characterization of a new Leishmania major strain for use in a controlled human infection model
Presentations
Homeostasis
PLANT MITOCHONDRIAL BIOLOGY
Photosynthesis
Endocrine Disorders
THE PITUITARY GLAND
Posters
ACMT 2020 Annual Scientific Meeting Abstracts - New York, NY
Abstracts from the 2020 Annual Scientific Meeting of the British and Irish Hypertension Society (…
ACNP 58th Annual Meeting: Poster Session III
ACNP 58th Annual Meeting: Poster Session II
ACNP 58th Annual Meeting: Poster Session I